Holen Sie sich die Stockscreener-App
1.33
8.13%
0.10
Vorhandelsmarkt:
1.26
-0.07
-5.26%
Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten
INO Stock Edges Up After Hours As Partner Reports Success In Cervical Dysplasia Trial - Stocktwits
ApolloBio reports positive phase 3 results for VGX-3100 in China - Investing.com UK
Positive Phase 3 Results for Inovio (INO) Partnered VGX-3100 in China - GuruFocus
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio (NASDAQ: INO) director awarded RSUs and 41,800 options - Stock Titan
[Form 4] INOVIO PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Inovio (NASDAQ: INO) grants RSUs and stock options to director Ann Calby Miller - Stock Titan
Equity grants to Inovio (NASDAQ: INO) director David Weiner disclosed - Stock Titan
Inovio (NASDAQ: INO) director receives RSUs and stock options grant - Stock Titan
Inovio (NASDAQ: INO) director granted 34,200 RSUs and 41,800 options - Stock Titan
INOVIO (INO) Chief Scientific Officer reports RSU vesting, tax withholding and new stock option awards - Stock Titan
Inovio (INO) CMO granted RSUs and 46,876 stock options at $1.73 - Stock Titan
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China - PR Newswire
Inovio (INO) CFO granted stock options, RSUs and reports RSU vesting - Stock Titan
Inovio (NASDAQ: INO) CEO receives new RSUs and options as shares withheld for taxes - Stock Titan
Inovio Shareholders Endorse Governance Changes and Leadership - TipRanks
Inovio Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus
Inovio (NASDAQ: INO) overhauls board roles and wins approval on all 2026 shareholder proposals - Stock Titan
Inovio Pharmaceuticals Q3 2025 Earnings Preview - MSN
Inovio Pharmaceuticals, Inc. Stock Alert: INO Stockholders Who L - GuruFocus
$Moderna (MRNA.US)$ $Inovio Pharmaceuticals (INO.US)$ $3M (MMM.US)$ - Moomoo
Earnings call transcript: Inovio beats Q1 2026 EPS forecast but stock slips - Investing.com UK
Earnings call transcript: Inovio beats Q1 2026 EPS forecast but stock slips By Investing.com - Investing.com South Africa
Inovio Stock Price Today | NASDAQ: INO Live - Investing.com
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Inovio (NASDAQ: INO) CEO nets shares from RSU vesting and tax withholding - Stock Titan
Inovio Pharmaceuticals (INO) CFO exercises 4,771 RSUs and has 2,571 shares withheld for taxes - Stock Titan
INOVIO (NASDAQ: INO) CSO settles RSUs, shares withheld for tax - Stock Titan
INOVIO (NASDAQ: INO) CMO vests RSUs and withholds shares for taxes - Stock Titan
Inovio Pharmaceuticals, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:INO) 2026-05-16 - Seeking Alpha
INO Should I Buy - Intellectia AI
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2026 Earnings Call Transcript - Insider Monkey
Highbridge reports 6.19M warrant‑issued shares in Inovio (INO) - Stock Titan
Investigation Alert: Investors who hold shares of Inovio - openPR.com
INOVIO Shares Drop 10% After Discounted $25 Million Public Offering - MSN
Inovio Pharmaceuticals stock (US45773H2013): Q1 2026 results and INO-3107 FDA review - AD HOC NEWS
Inovio: All Eyes On INO-3107 As Binary FDA Decision Looms (NASDAQ:INO) - Seeking Alpha
Q1 2026 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Inovio Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
INOVIO Reports First Quarter 2026 Financial Results and Recent B - GuruFocus
Inovio Pharmaceuticals Inc (INO) Q1 2026 Earnings Call Highlights: Progress and Challenges in Advancing INO-3107 - GuruFocus
Inovio outlines cash runway into Q1 2027 as INO-3107 targets October 30, 2026 PDUFA date - MSN
Inovio and Fossil Q1 results highlight strategic progress - MSN
Salt Lake City Topic INOVIO PHARMACEUTICALS, INC. | News, Weather, Sports, Breaking News - KMYU
Earnings call transcript: Inovio’s Q1 2026 highlights clinical progress, stock rises 2.84% - Investing.com UK
Inovio Pharmaceuticals (INO) Q1 2026 Earnings Report Highlights Progress and Cash Position - GuruFocus
Is Inovio Pharmaceuticals (INO) Still 545.2% Overvalued After Q1 - GuruFocus
Inovio (INO) Q1 2026 Earnings Call Transcript - AOL.com
Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call - Benzinga
Inovio Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Inovio’s Q1 2026 highlights clinical progress, stock rises 2.84% By Investing.com - Investing.com South Africa
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
INOVIO Pharmaceuticals posts first quarter 2026 results and reviews operations - Traders Union
Inovio Pharmaceuticals posts flat Q1 net loss - TradingView
Inovio: Q1 Earnings Snapshot - Barchart.com
INOVIO (NASDAQ: INO) details Q1 loss and INO-3107 accelerated FDA review - Stock Titan
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights - The Winchester Star
4.72%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):